Reporter brief
Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle.
What happened
Trial registry update: RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Study findings are not reported, so no conclusions about rapamycin's effects on aged muscle can be drawn from this material
- The small planned sample size (16 participants) limits generalizability regardless of results
- An abstract and aims statement do not constitute evidence of efficacy or safety
Study design and sample
Rct; Human.
Healthy male volunteers over 50 years old
- Design
- Rct
- Sample
- 16
- Journal
- University of Nottingham
- Published
- Apr 10, 2025
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Rapamycin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.